Loading menubar.....

Difference between revisions of "Team:Tuebingen/einweiterer"

 
(10 intermediate revisions by the same user not shown)
Line 1,714: Line 1,714:
 
         .offset-xl-11 {
 
         .offset-xl-11 {
 
             margin-left: 91.666667%
 
             margin-left: 91.666667%
 +
        }
 +
    }
 +
 +
    .veggie {
 +
        width: 100%;
 +
        max-width: 100%;
 +
        margin-bottom: 1rem;
 +
        background-color: transparent;
 +
        z-index:100;
 +
    }
 +
    .veggie td,
 +
    .veggie th {
 +
        padding: .75rem;
 +
        vertical-align: top;
 +
        border-top: 1px solid #F4F0DE;
 +
        color: #F4F0DE;
 +
        border-bottom: 1px solid #F4F0DE;
 +
        z-index:100;
 +
    }
 +
    .veggie th {
 +
        background-color: #2ecc71 !important;
 +
        color: #232323 !important;
 +
        z-index:100;
 +
    }
 +
    .veggie caption {
 +
        color: #adb3b7;
 +
        z-index:100;
 +
    }
 +
    .veggie thead th {
 +
        vertical-align: bottom;
 +
        border-bottom: 2px solid #dee2e6;
 +
        z-index:100;
 +
    }
 +
    .veggie tbody+tbody {
 +
        border-top: 2px solid #dee2e6;
 +
        z-index:100;
 +
    }
 +
 +
    @media screen and (max-width: 800px) {
 +
        .veggie {
 +
            font-size: xx-small;
 +
            z-index:100;
 
         }
 
         }
 
     }
 
     }
Line 1,916: Line 1,958:
 
             display: block;
 
             display: block;
 
             width: 100%;
 
             width: 100%;
             overflow-x: auto;
+
             overflow-x: break-words;
 
             -webkit-overflow-scrolling: touch;
 
             -webkit-overflow-scrolling: touch;
 
             -ms-overflow-style: -ms-autohiding-scrollbar
 
             -ms-overflow-style: -ms-autohiding-scrollbar
Line 1,930: Line 1,972:
 
             display: block;
 
             display: block;
 
             width: 100%;
 
             width: 100%;
             overflow-x: auto;
+
             overflow-x: break-words;
 
             -webkit-overflow-scrolling: touch;
 
             -webkit-overflow-scrolling: touch;
 
             -ms-overflow-style: -ms-autohiding-scrollbar
 
             -ms-overflow-style: -ms-autohiding-scrollbar
Line 1,944: Line 1,986:
 
             display: block;
 
             display: block;
 
             width: 100%;
 
             width: 100%;
             overflow-x: auto;
+
             overflow-x: break-words;
 
             -webkit-overflow-scrolling: touch;
 
             -webkit-overflow-scrolling: touch;
 
             -ms-overflow-style: -ms-autohiding-scrollbar
 
             -ms-overflow-style: -ms-autohiding-scrollbar
Line 6,034: Line 6,076:
  
 
     .bg-dark {
 
     .bg-dark {
         background-color: #343a40 !important
+
         background-color: #232323 !important
 
     }
 
     }
  
Line 9,283: Line 9,325:
  
 
     .dropdown-menu {
 
     .dropdown-menu {
         background-color: rgba(100, 100, 100, 1);
+
         background-color: #232323;
 
     }
 
     }
  
Line 10,240: Line 10,282:
 
                 <li id="ourStoryButton" class="nav-item mx-3">
 
                 <li id="ourStoryButton" class="nav-item mx-3">
 
                     <a class="nav-link" href="/Team:Tuebingen/Story"
 
                     <a class="nav-link" href="/Team:Tuebingen/Story"
                       style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">OUR STORY</a>
+
                       style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">OUR
 +
                        STORY</a>
 
                 </li>
 
                 </li>
  
Line 10,257: Line 10,300:
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Incretin"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Incretin"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Incretin</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Incretin</a>
                         <a class="dropdown-item" href="/Team:Tuebingen/CPP"
+
                         <a class="dropdown-item" href="/Team:Tuebingen/Model"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Cell Penetrating Peptides</a>
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Model</a>
 +
                        <a class="dropdown-item" href="/Team:Tuebingen/Software"
 +
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Software</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Results"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Results"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Results</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Results</a>
Line 10,265: Line 10,310:
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Notebook"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Notebook"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Notebook</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Notebook</a>
                        <a class="dropdown-item" href="/Team:Tuebingen/Model"
 
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Model</a>
 
                        <a class="dropdown-item" href="/Team:Tuebingen/Software"
 
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Software</a>
 
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Outlook"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Outlook"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Outlook</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Outlook</a>
 +
                        <a class="dropdown-item" href="/Team:Tuebingen/Entrepreneurship"
 +
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Entrepreneurship</a>
 
                     </div>
 
                     </div>
 
                 </li>
 
                 </li>
Line 10,280: Line 10,323:
 
                     <div class="dropdown-menu">
 
                     <div class="dropdown-menu">
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Parts"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Parts"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Parts Overview</a>
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Parts
 +
                            Overview</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Basic_Part"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Basic_Part"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Basic Parts</a>
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Basic
 +
                            Parts</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Improved_Part"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Improved_Part"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Improved Parts</a>
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Improved
 +
                            Parts</a>
 +
                        <a class="dropdown-item" href="/Team:Tuebingen/Characterized_Part"
 +
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Improved
 +
                            Parts</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Composite_Part"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Composite_Part"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Composite Parts</a>
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Composite
 +
                            Parts</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Part_Collection"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Part_Collection"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Part Collection</a>
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Part
 +
                            Collection</a>
 +
                        <a class="dropdown-item" href="/Team:Tuebingen/Downloads"
 +
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Downloads</a>
 
                     </div>
 
                     </div>
 
                 </li>
 
                 </li>
Line 10,302: Line 10,355:
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Collaborations"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Collaborations"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Collaborations</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Collaborations</a>
                        <a class="dropdown-item" href="/Team:Tuebingen/Attributions"
 
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Attributions</a>
 
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Sponsors"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Sponsors"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Sponsors</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Sponsors</a>
 +
                        <a class="dropdown-item" href="/Team:Tuebingen/Attributions"
 +
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Attributions</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Gallery"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Gallery"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Gallery</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Gallery</a>
Line 10,320: Line 10,373:
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Overview</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Overview</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Public_Engagement"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Public_Engagement"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Education & Public
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Education & Public Engagement</a>
                            Engagement</a>
+
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Experts"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Experts"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Experts</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Experts</a>
                        <a class="dropdown-item" href="/Team:Tuebingen/Entrepreneurship"
 
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Entrepreneurship</a>
 
 
                         <a class="dropdown-item" href="/Team:Tuebingen/SDG"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/SDG"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Sustainable Development
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Sustainable Development Goals</a>
                            Goals</a>
+
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Experimenta"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Experimenta"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Experimenta Science
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Experimenta
                             Center</a>
+
                             Science Center</a>
 +
                        <a class="dropdown-item" href="/Team:Tuebingen/Survey"
 +
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Survey</a>
 
                     </div>
 
                     </div>
 
                 </li>
 
                 </li>
Line 10,343: Line 10,394:
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Integrated Human Practise</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Integrated Human Practise</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Public_Engagement"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Public_Engagement"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Education & Public
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Education & Public Engagement</a>
                            Engagement</a>
+
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Entrepreneurship"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Entrepreneurship"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Supporting
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Supporting Entrepreneurship</a>
                            Entrepreneurship</a>
+
                        <a class="dropdown-item" href="/Team:Tuebingen/Measurement"
+
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Measurement</a>
+
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Model"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Model"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Model</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Model</a>
Line 10,364: Line 10,411:
 
                 <li class="nav-item mx-3">
 
                 <li class="nav-item mx-3">
 
                     <a class="nav-link" href="https://igem.org/2019_Judging_Form?team=Tuebingen" target="_blank"
 
                     <a class="nav-link" href="https://igem.org/2019_Judging_Form?team=Tuebingen" target="_blank"
                       style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">JUDGING
+
                       style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">JUDGING FORM ⇗</a>
                        FORM ⇗</a>
+
 
                 </li>
 
                 </li>
  
Line 10,575: Line 10,621:
 
         -webkit-transform: translateZ(0) scale(1.0, 1.0);
 
         -webkit-transform: translateZ(0) scale(1.0, 1.0);
 
         transform: translateZ(0);
 
         transform: translateZ(0);
         background: #1B2030 url(https://2019.igem.org/wiki/images/a/a0/T--Tuebingen--description-banner.jpg) center no-repeat;
+
         background: #1B2030 url(https://2019.igem.org/wiki/images/5/50/T--Tuebingen--experimenta-banner.jpg) center no-repeat;
 
         background-size: 100%, 100%;
 
         background-size: 100%, 100%;
 
         animation: grow 30s linear 10ms infinite;
 
         animation: grow 30s linear 10ms infinite;
Line 10,637: Line 10,683:
 
         }
 
         }
  
        .header {
+
 
            height:40vh
+
        }
+
 
     }
 
     }
  
    @media only screen and (max-width: 600px) {
+
 
        .header {
+
            height:35vh
+
        }
+
    }
+
  
 
     @media only screen and (max-width: 560px) {
 
     @media only screen and (max-width: 560px) {
Line 10,652: Line 10,692:
 
             margin-top: 15%;
 
             margin-top: 15%;
 
         }
 
         }
    }
 
 
    @media only screen and (max-width: 500px) {
 
 
         .header {
 
         .header {
             height:30vh
+
             height: 40vh;
 
         }
 
         }
 
     }
 
     }
 +
 +
  
 
     @media only screen and (max-width: 470px) {
 
     @media only screen and (max-width: 470px) {
Line 10,667: Line 10,706:
 
     }
 
     }
  
    @media only screen and (max-width: 450px) {
+
 
        .header {
+
            height:25vh
+
        }
+
    }
+
  
 
     @media only screen and (max-width: 400px) {
 
     @media only screen and (max-width: 400px) {
 
         .info h1 {
 
         .info h1 {
             margin-top: 15%;
+
             margin-top: 20%;
 +
        }
 +
        .header {
 +
            height: 27vh;
 
         }
 
         }
 
     }
 
     }
Line 10,681: Line 10,719:
 
     @media only screen and (max-width: 350px) {
 
     @media only screen and (max-width: 350px) {
 
         .info h1 {
 
         .info h1 {
             margin-top: 18%;
+
             margin-top: 25%;
 
         }
 
         }
 
     }
 
     }
Line 10,704: Line 10,742:
 
<div class="header">
 
<div class="header">
 
   <div class="info">
 
   <div class="info">
     <h1 style="font-family: 'Righteous', cursive; font-weight: normal; color:#2ecc71;">GLP.exe</h1>
+
     <h1 style="font-family: 'Righteous', cursive; font-weight: normal; color:#2ecc71;">Experimenta</h1>
 
   </div>
 
   </div>
 
</div>
 
</div>
Line 10,710: Line 10,748:
  
  
<div style="background-color: #232323;">
+
<div style="background-color: #232323; overflow-x: fragments; overflow-wrap: break-word">
  
 
<div class="glpContainer">
 
<div class="glpContainer">
Line 10,722: Line 10,760:
 
         <div id="image-popups">
 
         <div id="image-popups">
  
         <h2 style="font-family:'Righteous'; color:#2ecc71;">Abstract</h2>
+
         <h2 style="font-family:'Righteous'; color:#2ecc71;">The Experimenta Science Center Heilbronn</h2>
 
         <div class="row">
 
         <div class="row">
 
             <div class="col-12">
 
             <div class="col-12">
 
                 <p>
 
                 <p>
                     Diabetes Mellitus is one of the main diseases causing premature death worldwide [16].
+
                     The Experimenta Science Center (<a href="https://www.experimenta.science/" onclick='window.open("https://www.experimenta.science/","_self");'>Experimenta</a>) in Heilbronn, Baden-Wuerttemberg,
                    In 2014, 422 Million adults were diagnosed with Diabetes Mellitus worldwide [1], an
+
                     Germany offers science at your fingertips on an area of around 25,000 square metres with around 275
                    alarmingly high number. This inspired us to look into alternative treatment strategies for
+
                     interactive exhibits, four creative studios and nine laboratories, as well as an observatory and an
                    Type 2 Diabetes Mellitus, as it marks the largest group of Diabetes patients.
+
                     extraordinary science dome with spectacular science shows. Additionally, last year, they set up the
                    There already is a variety of treatment options, however they all require active participation
+
                     “Schülerforschungszentrum” (SFZ), where young researchers are actively supported in their initial
                    of the patients and compliance to their individual therapy schemes. As compliance and persistence
+
                     scientific work. It is directed at students from high schools in Heilbronn. Their general idea is to
                    are key factors for therapeutic success, we, the iGEM Team Tübingen, want to revolutionize
+
                     encourage students to develop their own projects while funding, lab space and supervision is granted.
                     the treatment and its administration with the use of Synthetic Biology. We therefore developed
+
                    GLP.exe a probiotic on the basis of Escherichia coli Nissle which secretes Exenatid, an incretin anologon,
+
                     in response to glucose. To ensure its safe use as a GMO we invented a CRISPR/Cas3-based kill-switch
+
                    integrated into our probiotic. This kill-switch is regulated by environmental factors and prevents
+
                    the release and spread of our GMO into the environment. Our probiotic allows for a single-time
+
                    application as it independently synthesises the drug when it is needed. To deepen our understanding
+
                    of our probiotic strain we also worked on characterising E.coli Nissle via different means such as
+
                    RNA-Seq and metabolic modelling. This characterisation will be benefitial for the iGEM and general
+
                     scientific community in future projects. The use of GMOs, especially in the medical field, is a
+
                    delicate topic and great efforts were made during our project to spread awareness and to educate
+
                    the public about synthetic biology, GMOs and Diabetes.
+
                </p>
+
                <p>
+
                     In order to design an impactful project for this year’s iGEM season, we deemed it important to
+
                     precisely understand and define the problem we wanted to work on.
+
                </p>
+
                <p>
+
                    Through extensive research into the factors impeding phage therapy, we identified the production
+
                    process to be one of the most striking problems. In particular, the current methods are inefficient,
+
                     lead to high impurities and contamination, require the cultivation of human pathogens in large
+
                    quantities and causes regulatory problems due to imprecise manufacturing standards and a lack of
+
                    adequate quality controls.
+
 
                 </p>
 
                 </p>
 
             </div>
 
             </div>
 +
        </div>
  
             <h2 style="font-family:'Righteous'; color:#2ecc71;">Project Inspiration</h2>
+
             <h2 style="font-family:'Righteous'; color:#2ecc71;">Our 4 Day Lab Course</h2>
 
             <div class="row">
 
             <div class="row">
 
                 <div class="col-12">
 
                 <div class="col-12">
                     <p>
+
                     <p>The course was held in a collaborative manner over a span of four days. Dr. Robert Friedrich,
                        When committing to iGEM, we decided we firstly wanted to design a project which uses a new
+
                         a biologist working for the SFZ, gave the general lab introduction and provided the overall lab
                        system of the field of synthetic biology, and secondly to make an impact with a product,
+
                         responsibility, while we were mainly responsible to teach the required theoretical background,
                        which can actually be of use to the society. So when Dr. Pengfei Xia, one of our advisors
+
                         introduce bioinformatics data analysis (DNA-Seq) and finally project development. Additionally,
                         proposed to design a new kill-switch system for bacteria, based on the Type I CRISPR system
+
                        we were supporting Dr. Friedrich during the experiments and closely supervised the students.</p>
                         CRISPR/Cas3, we were determined to not only implement the system, but also find a way of making
+
                </div>
                         it a useful, universally applicable, tool. As Diabetes Mellitus Type 2 becomes more and more
+
            </div>
                         epidemic, with some of our team members relatives also suffering from it, and a problem for
+
            <div class="row">
                        society and the healthcare system, we decided to focus our project on this disease.
+
                <div class="col-12">
                     </p>
+
                    <div class="row align-items-center">
 +
        <div class="col-12 col-md-6">
 +
        <figure>
 +
                         <a style="font-size: small"
 +
                          href="https://2019.igem.org/wiki/images/e/e8/T--Tuebingen--Experimenta-Lab4.png"
 +
                          data-effect="mfp-zoom-out"
 +
                          title="Some title">
 +
                            <img src="https://2019.igem.org/wiki/images/e/e8/T--Tuebingen--Experimenta-Lab4.png"
 +
                                class="figure-img img-fluid rounded"
 +
                                alt="Placeholder"></a>
 +
                     </figure>
  
                    <p>
+
        </div>
                        We thought about changes in therapy, which would make it easier to comply with the therapy
+
        <div class="col-12 col-md-6 ">
                        scheme and identified issues like the required daily injections and multiple drugs, which need
+
        <p>We conveyed the required theoretical background in a modern and interactive way, with the use of
                        to be taken at certain times during the day. Overall, we came to the conclusion that a probiotic
+
            smart boards and current web tools. We focused on teaching the highly motivated students cutting-edge
                        bacterium synthesising a drug when required, and therefore lifting the burden of application
+
            research, while providing a theoretical foundation, preparing them for different biology competitions
                        from the patient, would be our way to go. On top of that, we realized that in 2017 Team AQA_Unesp
+
            and eventually university.</p>
                        had already tried to target Type 1 Diabetes Mellitus with a probiotic, hence we felt that the
+
        </div>
                        viability of the idea was supported by this [7]. Additionally, this approach would allow us to
+
                    </div>
                        not only use our bacterium with the CRISPR/Cas3 system as biofactory, but also make it the
+
                </div>
                        therapeutic agent which is applied, making the biosafety function of CRISPR/Cas3, not only a
+
            </div>
                        tool, but also a requirement for safe application.</p>
+
  
 +
            <div class="row">
 +
                <div class="col-12">
 +
                    <div class="row align-items-center">
 +
        <div class="col-12 col-md-6">
 +
        <figure>
 +
                        <a style="font-size: small"
 +
                          href="https://2019.igem.org/wiki/images/9/94/T--Tuebingen--Experimenta-Lab3.png"
 +
                          data-effect="mfp-zoom-out"
 +
                          title="Some title">
 +
                            <img src="https://2019.igem.org/wiki/images/9/94/T--Tuebingen--Experimenta-Lab3.png"
 +
                                class="figure-img img-fluid rounded"
 +
                                alt="Placeholder"></a>
 +
                    </figure>
 +
 +
        </div>
 +
        <div class="col-12 col-md-6 ">
 +
        <figure>
 +
                        <a style="font-size: small"
 +
                          href="https://2019.igem.org/wiki/images/6/69/T--Tuebingen--Experimenta-Lab5.png"
 +
                          data-effect="mfp-zoom-out"
 +
                          title="Some title">
 +
                            <img src="https://2019.igem.org/wiki/images/6/69/T--Tuebingen--Experimenta-Lab5.png"
 +
                                class="figure-img img-fluid rounded"
 +
                                alt="Placeholder"></a>
 +
                    </figure>
 +
        </div>
 +
                    </div>
 
                     <p>
 
                     <p>
                         The idea of using GMOs as probiotics, is generally of great interest for chronic diseases.
+
                         Please check out the material we prepared for the course - a script covering all the theoretical
                        Therefore, we want to use the application in Type 2 Diabetes Mellitus as an example of the
+
                         background and a presentation:
                         strengths and limitations of such a system, and use our public involvement to gather the society’s
+
                    </p>
                        perception and opinion of such a therapeutic strategy. Overall, we consider our project to be
+
                    <ul style="color:#F4F0DE;">
                        an important trial for the use of synthetic biology in long-term therapy, during which the patient
+
                      <li><a href="https://2019.igem.org/wiki/images/6/6c/T--Tuebingen--Experimenta_Labkurs_Skript.pdf" onclick='window.open("https://2019.igem.org/wiki/images/6/6c/T--Tuebingen--Experimenta_Labkurs_Skript.pdf","_self");'>Experimenta Labkurs</a></li>
                        is not restricted to stay within a facility, but can live normally and without financial or other
+
                      <li><a href="https://2019.igem.org/wiki/images/1/10/T--Tuebingen--LabCoursePresentation.pdf" onclick='window.open("https://2019.igem.org/wiki/images/1/10/T--Tuebingen--LabCoursePresentation.pdf","_self");'>LabCourse Presentation</a>)</li>
                        burdens of the disease. By designing a safe system which will prohibit the survival of GMOs within
+
                    </ul>
                         the environment, our project aims at enabling the use of probiotics in modern therapy.
+
                    <p>
 +
                         Please see the schedule below.
 
                     </p>
 
                     </p>
 
                 </div>
 
                 </div>
 
             </div>
 
             </div>
  
             <h2 class="tocitem" style="text-align: left;font-family:'Righteous'; color:#2ecc71;">Glucose-dependent Incretin secretion</h2>
+
             <div class="row">
              <div class="row align-items-center">
+
                 <div class="col-12">
                 <div class="col-12 col-md-5">
+
 
                     <figure>
 
                     <figure>
 
                         <a style="font-size: small"
 
                         <a style="font-size: small"
                           href="https://2019.igem.org/wiki/images/4/45/T--Tuebingen--Glucose-dep-Incretin-system.png"
+
                           href="https://2019.igem.org/wiki/images/f/f1/T--Tuebingen--table_test.png"
 
                           data-effect="mfp-zoom-out"
 
                           data-effect="mfp-zoom-out"
 
                           title="Some title">
 
                           title="Some title">
                             <img src="https://2019.igem.org/wiki/images/4/45/T--Tuebingen--Glucose-dep-Incretin-system.png"
+
                             <img src="https://2019.igem.org/wiki/images/f/f1/T--Tuebingen--table_test.png"
 
                                 class="figure-img img-fluid rounded"
 
                                 class="figure-img img-fluid rounded"
 
                                 alt="Placeholder"></a>
 
                                 alt="Placeholder"></a>
 
                     </figure>
 
                     </figure>
        </div>
+
                </div>
    <div class="col-12 col-md-7">
+
        <p>
+
            Our probiotic secretes Exenatid-4, an Incretin mimetic, in response to glucose availability in
+
                        the human gut. The system works via the carbon catabolite repression system which will initiate
+
                        the transcription of tetR. Upstream of our Exenatid-4 is a TetR repressible promoter, which ensures
+
                        that Exenatid-4 is only transcribed in the presence of glucose. Furthermore, our Exenatid-4 is
+
                        coupled to an N-terminal secretion tag and a C-terminal cell penetrating peptide (CPP), which
+
                        together ensure the secretion and uptake of our drug increasing its bioavailability. Due to the
+
                        immense variety of CPPs and the lack of quantitative information about their efficiency, we also
+
                        developed a <a href="https://2019.igem.org/Team:Tuebingen/Software">predictive software tool</a>
+
                        to allow for educated decisions on the design of CPPs.[LINK ZU INCRETIN SEITE]
+
        </p>
+
    </div>
+
</div>
+
 
             </div>
 
             </div>
  
 
            <h2 style="font-family:'Righteous';">CRISPR/Cas3 kill-switch</h2>
 
 
             <div class="row">
 
             <div class="row">
 
                 <div class="col-12">
 
                 <div class="col-12">
                     <p>
+
                     <p>Due to the interactive design of the course, we also discussed the experiments with the students
                        The implemented and newly developed CRISPR/Cas3 kill-switch allows for the safe use of our probiotic.
+
                         and tried to summarize what we did on the blackboard:</p>
                        Once the kill-switch is activated the Cas3 nuclease degrades the bacterial nucleic acid and therefore
+
                        prevents the spread of GMOs into the environment. The kill switch is regulated by three environmental
+
                        factors which are common in a healthy humans intestine: 37°C, availability of fatty acids in form of
+
                        Acyl-CoA and N-Acetyl-Glucosamin (GlcNAc), released by the metabolism of mucus through commensal
+
                        microorganisms [9]. As soon as the probiotic leaves its designated area, the repression of the
+
                         kill switch is abrogated and the CRISPR/Cas3 system activated. The kill-switch therefore, is a
+
                        concept that can be used for a diverse spectrum of therapies by exchanging the drug and/or the conditions.
+
                    </p>
+
                </div>
+
  
                <figure>
+
                    <div class="row align-items-center">
 +
        <div class="col-12 col-md-6">
 +
        <figure>
 
                         <a style="font-size: small"
 
                         <a style="font-size: small"
                           href="https://2019.igem.org/wiki/images/5/57/T--Tuebingen--Kill-Switch-desc-transparent.png"
+
                           href="https://2019.igem.org/wiki/images/b/be/T--Tuebingen--Experimenta-Lab1.png"
 
                           data-effect="mfp-zoom-out"
 
                           data-effect="mfp-zoom-out"
 
                           title="Some title">
 
                           title="Some title">
                             <img src="https://2019.igem.org/wiki/images/5/57/T--Tuebingen--Kill-Switch-desc-transparent.png"
+
                             <img src="https://2019.igem.org/wiki/images/b/be/T--Tuebingen--Experimenta-Lab1.png"
 
                                 class="figure-img img-fluid rounded"
 
                                 class="figure-img img-fluid rounded"
                                 alt="A generic square placeholder image with rounded corners in a figure."></a>
+
                                 alt="Placeholder"></a>
 
                     </figure>
 
                     </figure>
                </div>
 
  
 +
        </div>
 +
        <div class="col-12 col-md-6 ">
 +
        <figure>
 +
                        <a style="font-size: small"
 +
                          href="https://2019.igem.org/wiki/images/d/df/T--Tuebingen--Experimenta-Lab2.png"
 +
                          data-effect="mfp-zoom-out"
 +
                          title="Some title">
 +
                            <img src="https://2019.igem.org/wiki/images/d/df/T--Tuebingen--Experimenta-Lab2.png"
 +
                                class="figure-img img-fluid rounded"
 +
                                alt="Placeholder"></a>
 +
                    </figure>
 +
        </div>
 +
                    </div>
 +
                </div>
 +
            </div>
  
            <h2 style="font-family:'Righteous';">E.coli Nissle Characterisation</h2>
 
 
             <div class="row">
 
             <div class="row">
 
                 <div class="col-12">
 
                 <div class="col-12">
 +
                    <p>The students were also very interested in iGEM and our work. Hence, we not only introduced iGEM
 +
                        and our project to them, but also let them critically evaluate our project. They were also given
 +
                        the chance to conduct PCRs related to our project and could therefore gain insights into the upcoming
 +
                        challenges when starting a new project or experiment where not everything has been optimised for
 +
                        easy functionality. Many students were interested in the iGEM competition itself and in the process
 +
                        of finding a project and making it feasible. Therefore, we also invested into giving valuable input
 +
                        and advice on starting a project and encouraged the students to participate in iGEM or similar projects
 +
                        themselves. Several questions and concerns relating the functionality of our probiotic under different
 +
                        conditions, such as patients taking medications or antibiotics were also raised by the students. These
 +
                        fruitful discussions, as well as our exchange with several experts, contributed to the final design
 +
                        of our RNA-Seq experiment providing valuable input and different aspects to be considered
 +
                        [<a href="https://2019.igem.org/Team:Tuebingen/Experts" onclick='window.open("https://2019.igem.org/Team:Tuebingen/Experts","_self");'>Experts</a>, <a href="https://2019.igem.org/Team:Tuebingen/Nissle" onclick='window.open("https://2019.igem.org/Team:Tuebingen/Nissle","_self");'>Nissle</a>].</p>
 +
 
                     <p>
 
                     <p>
                         Despite the wide use of E.coli Nissle (EcN) it is not characterised well enough. To enhance our
+
                         Due to the high interest of the students and the positive feedback from the Experimenta itself,
                        knowledge of EcN and to provide crucial information to the scientific community as well as future
+
                         we discussed the possibility of creating an iGEM high school team in Heilbronn in 2020.
                         iGEM teams, we investigated EcN’s transcriptome under different stress conditions. Understanding
+
                         The Experimenta is highly interested in participating in iGEM 2020 with motivated students and
                        the complete transcriptome, the expressed genes, post-transcriptional modifications,
+
                         will provide the required laboratories, supervision and funding. Our team will still be serving
                        single-nucleotide polymorphisms (SNPs) and additional properties of interest is essential for
+
                         as advisors for the planned iGEM high school team next year. Furthermore, a new student lab course
                         understanding genetic causes of adaptations to stress. The gained insight could
+
                         on CRISPR/Cas will be introduced at the Experimenta on the grounds of the theoretical background,
                         lead to the development of more stress resistant strains, improving probiotic treatment to a
+
                         input and inspiration iGEM Tuebingen conveyed.
                        large degree. Hence, we conducted large-scale RNA-Seq experiments for 12 conditions including
+
                        aerobic and anaerobic environments. The conditions were chosen after a thorough evaluation of
+
                         EcN’s growth under different strengths of the stress conditions. Additionally, we created the
+
                         <a href="https://2019.igem.org/Team:Tuebingen/Model">first ever metabolic model</a> of EcN and
+
                        made it available to the iGEM and general scientific community.
+
                        Moreover, we modelled <a href="https://2019.igem.org/Team:Tuebingen/Nissle">the interaction of EcN</a>
+
                         with three different bacterial communities -
+
                        cutting-edge research and a novelty in the iGEM competition.
+
 
                     </p>
 
                     </p>
 
                 </div>
 
                 </div>
 
             </div>
 
             </div>
  
             <h2 style="font-family:'Righteous'; color:#2ecc71;">Software</h2>
+
             <h3 style="font-family:'Righteous'; color:#2ecc71;">Panel Discussion - „Biohacking – genetic experiments done at home“</h3>
 
+
 
+
 
             <div class="row">
 
             <div class="row">
 
                 <div class="col-12">
 
                 <div class="col-12">
 +
                    <p>In addition to the lab course, we also decided to host a panel discussion at the Experimenta.
 +
                        At the beginning of the <a href="https://2019.igem.org/wiki/images/2/24/T--Tuebingen--panelDiscussion.pdf" onclick='window.open("https://2019.igem.org/wiki/images/2/24/T--Tuebingen--panelDiscussion.pdf","_self");'>panel discussion</a>, we gave a talk about on the CRISPR / Cas method itself.
 +
                        We also included an overview of our ongoing project and the iGEM competition in general.</p>
 +
 
                     <p>
 
                     <p>
                         To transport Exendin-4 across the membrane of the enterocytes in the gut, we decided to utilize
+
                         In collaboration with Dr. Robert Friedrich, we designed a discussion around the status of current
                        cell-penetrating peptides (CPPs) as a carrier. CPPs have already been proven to transport different
+
                         research on CRISPR / Cas, the effectiveness of the method and its limitations, the prospects of
                         cargos like insulin, from the gut to the bloodstream [98].  To better understand the mechanism
+
                         future CRISPR / Cas developments, the availability and legality of so-called Do-It-Yourself CRISPR /
                         of action of CPPs and to make an educated decision for choosing the CPP domain in our project
+
                        Cas Kits and the ethical implications on society. The panel consisted out of Prof. Dr. Christoph
                         design, we decided to generate a machine learning model to predict the cargo transport efficiency.
+
                         Thyssen (<a href="www.bio.uni-kl.de/organisation/mitarbeiter/s-u/thyssen-christoph/" onclick='window.open("www.bio.uni-kl.de/organisation/mitarbeiter/s-u/thyssen-christoph/","_self");'>Christoph Thyssen</a>), an expert for subject
 +
                        didactics in biology and two of our team members - Marietheres Evers and Famke Baeuerle.
 
                     </p>
 
                     </p>
                     <p>
+
 
                        CPPs gain more and more attention in the scientific field, with multiple peptides being in clinical
+
                     <div class="row align-items-center">
                        trials to deliver drug molecules to target sites in patients [99]. Since they can be used in
+
        <div class="col-12 col-md-6">
                        various transport scenarios,  many iGEM teams submitted CPPs to the registry in the past years.
+
        <figure>
                        Therefore, we made our transport effectivity quantification software available to all future
+
                        iGEM teams and the scientific community. To ensure excellent usability, <a href="https://2019.igem.org/Team:Tuebingen/Software">
+
                        we implemented a web</a> GUI that allows multiple input formats.
+
                    </p>
+
                </div>
+
            </div>
+
                <figure>
+
 
                         <a style="font-size: small"
 
                         <a style="font-size: small"
                           href="https://2019.igem.org/wiki/images/2/23/T--Tuebingen--CPP-function-transparent.png"
+
                           href="https://2019.igem.org/wiki/images/5/54/T--Tuebingen--Biohacking_05.jpg"
 
                           data-effect="mfp-zoom-out"
 
                           data-effect="mfp-zoom-out"
 
                           title="Some title">
 
                           title="Some title">
                             <img src="https://2019.igem.org/wiki/images/2/23/T--Tuebingen--CPP-function-transparent.png"
+
                             <img src="https://2019.igem.org/wiki/images/5/54/T--Tuebingen--Biohacking_05.jpg"
 
                                 class="figure-img img-fluid rounded"
 
                                 class="figure-img img-fluid rounded"
                                 alt="A generic square placeholder image with rounded corners in a figure."></a>
+
                                 alt="Placeholder"></a>
 
                     </figure>
 
                     </figure>
  
            <div class="row">
+
        </div>
                <div class="col-12">
+
        <div class="col-12 col-md-6 ">
                    <h3 style="font-family:'Righteous'; color:#2ecc71;">Human Practices & Public Outreach</h3>
+
        <figure>
 +
                        <a style="font-size: small"
 +
                          href="https://2019.igem.org/wiki/images/4/4d/T--Tuebingen--Biohacking_10.jpg"
 +
                          data-effect="mfp-zoom-out"
 +
                          title="Some title">
 +
                            <img src="https://2019.igem.org/wiki/images/4/4d/T--Tuebingen--Biohacking_10.jpg"
 +
                                class="figure-img img-fluid rounded"
 +
                                alt="Placeholder"></a>
 +
                    </figure>
 +
        </div>
 +
                    </div>
 
                     <p>
 
                     <p>
                         Since our project involves the use of GMOs, which are a constant topic of debate, we realised
+
                         A lot of questions were asked during the <a href="https://2019.igem.org/wiki/images/1/13/T--Tuebingen--Panel_discussion_allg.pdf" onclick='window.open("https://2019.igem.org/wiki/images/1/13/T--Tuebingen--Panel_discussion_allg.pdf","_self");'>panel discussion</a> and the presentation. We discussed
                        that we needed to invest into spreading awareness and especially <a href="https://2019.igem.org/Team:Tuebingen/Public_Engagement">education about GMOs</a>,
+
                         the ethical implications of the CRISPR / Cas Method with the audience. Surprisingly,
                        synthetic biology and Diabetes.
+
                         many participants were eager to talk about scenarios they have heard about.
                        We therefore contacted <a href="https://2019.igem.org/Team:Tuebingen/Experts">several experts</a> and teamed
+
                         up with a variety of institutions, researchers and also iGEM teams in order to address this.
+
                        Several <a href="https://2019.igem.org/Team:Tuebingen/Collaborations">collaborations</a>, meetups, exchanges
+
                         and talks provided us with valuable information for our project and helped developing it over
+
                        the year. Learn more about our Human Practices under <a href="https://2019.igem.org/Team:Tuebingen/Human_Practices">Human Practices</a> / Overview.
+
 
                     </p>
 
                     </p>
 
                 </div>
 
                 </div>
 
             </div>
 
             </div>
  
 +
            <h3 style="font-family:'Righteous'; color:#2ecc71;">Outlook - Advisors of the Experimenta iGEM team 2020 & New student lab course</h3>
 
             <div class="row">
 
             <div class="row">
 
                 <div class="col-12">
 
                 <div class="col-12">
                     <h2 style="font-family:'Righteous';">Wetlab Project Plan</h2>
+
                     <p>During the collaboration with the Experimenta Heilbronn, we sat together with Dr. Robert Friedrich
 +
                        and Norbert Hommrichhausen to discuss the foundation of an iGEM high school team at the Experimenta
 +
                        Heilbronn. The Experimenta is highly interested in starting a team in Heilbronn and the motivated
 +
                        and interested students encouraged us to team up and further pursue this plan. Plans for an iGEM
 +
                        high school team 2020 were made, in which the Experimenta Heilbronn will be the main partner
 +
                        providing lab space, supervision and funding. The role of the iGEM Team Tuebingen is that of
 +
                        experienced advisors, who can assist in questions concerning the iGEM competition itself, the
 +
                        workflow of an iGEM year, as well as deliver expert knowledge and guidance in the laboratory or
 +
                        in questions concerning bioinformatics, design and human practices. Both the Experimenta and the
 +
                        iGEM Team Tuebingen aim at establishing a long-term collaboration in the scope of iGEM.</p>
  
 
                     <p>
 
                     <p>
                         To conclude, our projects required intensive cloning of multiple regulatory elements. For the parts, we used Biobricks that were sent with the 2019 shipping, Biobrick sequences from the database of iGEM, as well as new sequences, which are unique to our project, like the Exendin-4 fusion construct or the GlcNAc-6-P sensing system. After synthesis, the GOI constructs were amplified and cloned into vectors. These were used to transform competent E. coli cells that are commonly used for cloning applications, as they can be manipulated easily. Here, we can already test whether our GOI construct works and Exendin-4 is secreted in a glucose dependent manner.
+
                         Next to the foundation of a high school iGEM team, the Experimenta will also introduce new lab
 +
                        courses for school classes, one of them being a CRISPR/Cas course. The theoretical background,
 +
                        first steps and foundation of this course arose from the collaboration with iGEM Tuebingen this year.
 +
                        A more detailed outline and implementation of the course will be part of another collaboration
 +
                        between the Experimenta and iGEM Tuebingen.
 
                     </p>
 
                     </p>
 
                    <p>
 
                        At the same time the Cas3 system was isolated from E. coli K12, and the DNA with regulatory
 
                        system was changed in E. coli K12 to our individual sensing mechanisms. The functionality of
 
                        the kill switch and the different conditions for it can be tested already. If the construct
 
                        shows the desired activity, it can be integrated into the E. coli Nissle 1917 genome.
 
                        Finally, we hoped to combine our GOI with the Cas3 positive E. coli Nissle 1917 and test the
 
                        functionality of our system as a whole. More precisely, we wanted to test if the generated strain  secretes Exendin-4 in the presence of glucose, and if it destructs itself under conditions diverting from the gut.
 
                    </p>
 
                    <p>
 
                        In the future, we will proceed with experiments on human cell lines. Firstly, the transport of the Exendin-4 through a CaCo-2 cell monolayer will be tested to investigate, whether there will be a drug, which can reach the pancreas. Secondly, we will work with Rat Insulinoma cell line INS-1 cells, to examine whether Exendin-4 will induce an Insulin expression.
 
                    </p>
 
 
 
                 </div>
 
                 </div>
 
             </div>
 
             </div>
 
            <div id="glpreferences" class="row">
 
                <h3 style="font-family:'Righteous'; color: #2ecc71;">References</h3>
 
                <div class="col-12">
 
                    <ol>
 
                        <li><a href=https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf;jsessionid=8D5E18D2A5627102F238B7D2DA7AD2C4?sequence=1> World Health Organization. (2016).
 
                            Global Report on Diabetes. Available online; [Accessed 26.03.2019].</a></li>
 
                        <li id="ref_2"><a href=https://www.physiology.org/doi/abs/10.1152/physrev.00034.2006> Jens Juul Holst. The Physiology of Glucagon-like Peptide 1. (2007). Physiological Reviews. p.1409-1439.</a></li>
 
                        <li id="ref_3" style="color: #F4F0DE;">
 
                            Lim, Gareth E., Brubaker, Patricia L. Glucagon-Like Peptide 1 Secretion by the L-Cell. (2006). 10.2337/db06-S020. Diabetes. p. S70-S77</li>
 
                        <li id="ref_4" style="color: #F4F0DE;">Copley, Kathrin & McCowen, Kevin & Hiles, Richard & L Nielsen, Loretta & Young, Andrew & Parkes, David. (2006). Investigation of Exenatide Elimination and Its In Vivo and In Vitro Degradation. Current drug metabolism. 7. 367-74. 10.2174/138920006776873490.</li>
 
                        <li id="ref_5" style="color: #F4F0DE;">Duan F, Curtis KL, March JC. Secretion of insulinotropic proteins by commensal bacteria: rewiring the gut to treat diabetes. Appl Environ Microbiol. (2008);74(23):7437–7438. doi:10.1128/AEM.01019-08</li>
 
                        <li id="ref_6" style="color: #F4F0DE;">Duan FF, Liu JH, March JC. Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes. Diabetes. (2015);64(5):1794–1803. doi:10.2337/db14-0635</li>
 
                        <li id="ref_7" style="color: #F4F0DE;"><a href="http://2017.igem.org/Team:AQA_Unesp">iGEM Team AQA_Unesp</a></li>
 
                        <li id="ref_8"><a href="http://2012.igem.org/Team:NTU-Taida/Project/Circuit">Team NTU-Taida</a></li>
 
                        <li id="ref_9" style="color: #F4F0DE;">Sicard JF, Le Bihan G, Vogeleer P, Jacques M, Harel J. Interactions of Intestinal Bacteria with Components of the Intestinal Mucus. Front Cell Infect Microbiol. (2017);7:387. Published 2017 Sep 5. doi:10.3389/fcimb.2017.00387</li>
 
                        <li id="ref_10" style="color: #F4F0DE;">Barnhart MM, Lynem J, Chapman MR. GlcNAc-6P levels modulate the expression of Curli fibers by Escherichia coli. J Bacteriol. (2006);188(14):5212–5219. doi:10.1128/JB.00234-06</li>
 
                        <li id="ref_11" style="color: #F4F0DE;">Konopka JB. N-acetylglucosamine (GlcNAc) functions in cell signaling. Scientifica (Cairo). (2012);2012:489208. doi:10.6064/2012/489208</li>
 
                        <li id="ref_12"><a href="https://www.uniprot.org/uniprot/P0A8V6">uniprot</a> accessed: 19 Jun 2019</li>
 
                        <li id="ref_13" style="color: #F4F0DE;">Feng Y, Cronan JE. Crosstalk of Escherichia coli FadR with global regulators in expression of fatty acid transport genes. PLoS One. (2012);7(9):e46275. doi:10.1371/journal.pone.0046275</li>
 
                        <li id="ref_14" style="color: #F4F0DE;">Federle MJ. Autoinducer-2-based chemical communication in bacteria: complexities of interspecies signaling. Contrib Microbiol. (2009);16:18–32. doi:10.1159/000219371</li>
 
                        <li id="ref_15" style="color: #F4F0DE;">Griffiths AJF, Miller JH, Suzuki DT, et al. An Introduction to Genetic Analysis. 7th edition. New York: W. H. Freeman; (2000). Catabolite repression of the lac operon: positive control. Available from: <a href="https://www.ncbi.nlm.nih.gov/books/NBK22065/"></a></li>
 
                        <li id="ref_16" style="color: #F4F0DE;">IDF (International Diabetes Federation. IDF Diabetes Atlas. (2017). Eighth Edition. Available from: <a href="https://diabetesatlas.org/resources/2017-atlas.html"></a></li>
 
                        <li id="ref_17"><a href="https://www.experimenta.science/">Experimenta</a></li>
 
                        <li id="ref_18" style="color: #F4F0DE;"><a href="https://www.un.org/sustainabledevelopment/">UN-SDG</a> accessed: 01 May 2019 logos retrieved from here according to their guidelines</li>
 
                        <li id="ref_19" style="color: #F4F0DE;"><a href="https://igem-tuebingen.com/human_practices">Tuebingen:Human_Practices</a> survey available under the link</li>
 
                        <li id="ref_20" style="color: #F4F0DE;"><a href="https://2019.igem.org/Team:Costa_Rica/SDG-Challenge">Team CostaRica SDG</a> iGEMxSDGs page</li>
 
                        <li id="ref_21" style="color: #F4F0DE;"><a href="https://forms.gle/xtoeMHuAMpDHeaCc9">Team Taipei video conference</a></li>
 
                        <li id="ref_22" style="color: #F4F0DE;"><a href="https://www.jenabioscience.com/probes-epigenetics/cell-labeling/protein-and-nucleic-acid-internalization/single-cell-penetrating-peptides-cpps/cpp-p01-penetratin">Jenabioscience</a></li>
 
                        <li id="ref_98" style="color: #F4F0DE;"><a href="https://doi.org/10.1016/j.jconrel.2008.08.001">https://doi.org/10.1016/j.jconrel.2008.08.001</a></li>
 
                        <li id="ref_99" style="color: #F4F0DE;"><a href="https://doi.org/10.3390/molecules24050927">https://doi.org/10.3390/molecules24050927</a></li>
 
                    </ol>
 
                </div>
 
            </div>
 
            </div>
 
            </main>
 
 
         </div>
 
         </div>
 +
    </main>
 +
</div>
 
</div>
 
</div>
  

Latest revision as of 21:49, 19 October 2019

GLP.exe

Experimenta

The Experimenta Science Center Heilbronn

The Experimenta Science Center (Experimenta) in Heilbronn, Baden-Wuerttemberg, Germany offers science at your fingertips on an area of around 25,000 square metres with around 275 interactive exhibits, four creative studios and nine laboratories, as well as an observatory and an extraordinary science dome with spectacular science shows. Additionally, last year, they set up the “Schülerforschungszentrum” (SFZ), where young researchers are actively supported in their initial scientific work. It is directed at students from high schools in Heilbronn. Their general idea is to encourage students to develop their own projects while funding, lab space and supervision is granted.

Our 4 Day Lab Course

The course was held in a collaborative manner over a span of four days. Dr. Robert Friedrich, a biologist working for the SFZ, gave the general lab introduction and provided the overall lab responsibility, while we were mainly responsible to teach the required theoretical background, introduce bioinformatics data analysis (DNA-Seq) and finally project development. Additionally, we were supporting Dr. Friedrich during the experiments and closely supervised the students.

We conveyed the required theoretical background in a modern and interactive way, with the use of smart boards and current web tools. We focused on teaching the highly motivated students cutting-edge research, while providing a theoretical foundation, preparing them for different biology competitions and eventually university.

Please check out the material we prepared for the course - a script covering all the theoretical background and a presentation:

Please see the schedule below.

Due to the interactive design of the course, we also discussed the experiments with the students and tried to summarize what we did on the blackboard:

The students were also very interested in iGEM and our work. Hence, we not only introduced iGEM and our project to them, but also let them critically evaluate our project. They were also given the chance to conduct PCRs related to our project and could therefore gain insights into the upcoming challenges when starting a new project or experiment where not everything has been optimised for easy functionality. Many students were interested in the iGEM competition itself and in the process of finding a project and making it feasible. Therefore, we also invested into giving valuable input and advice on starting a project and encouraged the students to participate in iGEM or similar projects themselves. Several questions and concerns relating the functionality of our probiotic under different conditions, such as patients taking medications or antibiotics were also raised by the students. These fruitful discussions, as well as our exchange with several experts, contributed to the final design of our RNA-Seq experiment providing valuable input and different aspects to be considered [Experts, Nissle].

Due to the high interest of the students and the positive feedback from the Experimenta itself, we discussed the possibility of creating an iGEM high school team in Heilbronn in 2020. The Experimenta is highly interested in participating in iGEM 2020 with motivated students and will provide the required laboratories, supervision and funding. Our team will still be serving as advisors for the planned iGEM high school team next year. Furthermore, a new student lab course on CRISPR/Cas will be introduced at the Experimenta on the grounds of the theoretical background, input and inspiration iGEM Tuebingen conveyed.

Panel Discussion - „Biohacking – genetic experiments done at home“

In addition to the lab course, we also decided to host a panel discussion at the Experimenta. At the beginning of the panel discussion, we gave a talk about on the CRISPR / Cas method itself. We also included an overview of our ongoing project and the iGEM competition in general.

In collaboration with Dr. Robert Friedrich, we designed a discussion around the status of current research on CRISPR / Cas, the effectiveness of the method and its limitations, the prospects of future CRISPR / Cas developments, the availability and legality of so-called Do-It-Yourself CRISPR / Cas Kits and the ethical implications on society. The panel consisted out of Prof. Dr. Christoph Thyssen (Christoph Thyssen), an expert for subject didactics in biology and two of our team members - Marietheres Evers and Famke Baeuerle.

A lot of questions were asked during the panel discussion and the presentation. We discussed the ethical implications of the CRISPR / Cas Method with the audience. Surprisingly, many participants were eager to talk about scenarios they have heard about.

Outlook - Advisors of the Experimenta iGEM team 2020 & New student lab course

During the collaboration with the Experimenta Heilbronn, we sat together with Dr. Robert Friedrich and Norbert Hommrichhausen to discuss the foundation of an iGEM high school team at the Experimenta Heilbronn. The Experimenta is highly interested in starting a team in Heilbronn and the motivated and interested students encouraged us to team up and further pursue this plan. Plans for an iGEM high school team 2020 were made, in which the Experimenta Heilbronn will be the main partner providing lab space, supervision and funding. The role of the iGEM Team Tuebingen is that of experienced advisors, who can assist in questions concerning the iGEM competition itself, the workflow of an iGEM year, as well as deliver expert knowledge and guidance in the laboratory or in questions concerning bioinformatics, design and human practices. Both the Experimenta and the iGEM Team Tuebingen aim at establishing a long-term collaboration in the scope of iGEM.

Next to the foundation of a high school iGEM team, the Experimenta will also introduce new lab courses for school classes, one of them being a CRISPR/Cas course. The theoretical background, first steps and foundation of this course arose from the collaboration with iGEM Tuebingen this year. A more detailed outline and implementation of the course will be part of another collaboration between the Experimenta and iGEM Tuebingen.